Novartis Investigative Site

Little Rock, Arkansas 72204

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Sarcopenia Clinical Trial
Dose Range Finding Study in Sarcopenia
Status: Enrolling, Phase II
Updated: 3/24/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU
Status: Enrolling, Phase II
Updated: 1/5/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Chronic Heart Failure With Reduced Ejection Fraction. Clinical Trial
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Atherosclerosis Clinical Trial
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents
Status: Enrolling, Phase III
Updated: 3/8/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Chronic Heart Failure Clinical Trial
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
Status: Enrolling, Phase III
Updated: 2/21/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Hypertension Clinical Trial
An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Status: Enrolling, Phase III
Updated: 2/8/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials